key: cord-0702512-7jtobi9b authors: Gaber Mohamed Hamed, Mohammed; Samir Hagag, Radwa title: The Possible Immunoregulatory and Anti-Inflammatory Effects of Selective Serotonin Reuptake Inhibitors in Coronavirus Disease Patients date: 2020-07-26 journal: Med Hypotheses DOI: 10.1016/j.mehy.2020.110140 sha: aefa9f05f804120c7315d9893fd5766ade90610d doc_id: 702512 cord_uid: 7jtobi9b While researchers are struggling to develop a vaccine for coronavirus disease, it is important to evolve effective therapeutic strategies to save lives. The majority of coronavirus disease deaths are due to pneumonia. Mostly, stress and depression are associated with coronavirus disease infection and thus, resulting in weakening of patients’ immune response and hence, more severe respiratory symptoms or even death. We propose using a class of antidepressants named selective serotonin reuptake inhibitors for their reported potential antiviral effect, modulatory effect of respiratory symptoms, antioxidant properties and immunoregulatory effects beside their main action as antidepressant. In addition, the low cost of selective serotonin reuptake inhibitors might add a benefit for coronavirus disease patients. While researchers are struggling to develop a vaccine for coronavirus disease, it is important to evolve effective therapeutic strategies to save lives. The majority of coronavirus disease deaths are due to pneumonia. Mostly, stress and depression are associated with coronavirus disease infection and thus, resulting in weakening of patients' immune response and hence, more severe respiratory symptoms or even death. We propose using a class of antidepressants named selective serotonin reuptake inhibitors for their reported potential antiviral effect, modulatory effect of respiratory symptoms, antioxidant properties and immunoregulatory effects beside their main action as antidepressant. In addition, the low cost of selective serotonin reuptake inhibitors might add a benefit for coronavirus disease patients. In December 2019, the world health organization (WHO) had reported a sudden elevation in the incidence of pneumonia in Wuhan city, China without a known relevant cause [1] . These raised levels in pneumonia cases were then attributed to the newly diagnosed coronavirus disease Critically ill patients had shown symptoms of either mild or severe cytokine storms due to over activity of the immune system which is a major cause of death. This cytokine storm releases different inflammatory mediators, mainly IL-6 [13] . Early data regarding the current COVID-19 pandemic suggests that 60% of patients admitted to the intensive care unit (ICU) required mechanical ventilation, and the acute respiratory destress syndrome (ARDS) associated with pneumonia was diagnosed in about 40% of patients treated in the ICU [7] . Moreover, studies of COVID-19 had reported that pneumonia and ARDS are a consequence of coagulopathy and pulmonary embolus [8, 9] . If ARDS could be prevented or mitigated, we can expect a significant reduction in COVID-19 associated mortality [10] . People of all ages may have an increased risk of serious illnesses and unfortunately, till now, there is no available vaccine to protect against COVID-19 and no definitive and effective radical treatment for COVID-19. Therefore, Ministry of health in the affected countries had advised their civils to protect their selves from exposure to the infected subjects [11, 12] . The pandemic of COVID-19 has shown to affect people physically and psychologically [13] . The associated stress, anxiety and depression had shown to be responsible for a part in the pathogenesis of COVID-19 [14, 15] . Stress is defined as the process by which environmental requirements transform the organism's adaptability, leading to psychological and biological changes [14] . Clinical evidences have proved an association between specific mood disorders, caused by sustained or chronic stress and the immune dysregulation [15] [16] [17] . A study conducted on COVID-19 patients had reported that the severe cases are caused by a malfunction or deficiency in the immune system [18] . Immune dysregulation is a consequence of elevation of cortisol, the stress hormone, and reduction of serotonin [19] . This hormonal dysregulation might promote the initiation and progression of the infection [20] . In addition, stressful conditions associated with infection had shown to cause an elevation in the levels of the inflammatory mediator IL-6 that causes a decrease in the number and activity of cytotoxic T-cells and natural killer (NK) cells [21, 22] . Moreover, the resulted depression due to prolonged stress was found to be associated with higher levels of serum IL-6 and tumor necrosis factor-alfa (TNF-α) [22] , catecholamines, inhibitory T cells and histamine [14] . The decreased counts of lymphocytes, monocytes, eosinophils and basophils associated with depression had shown to participate more in suppressing the immune response [23, 24] . These elevated inflammatory cytokines had shown also to precipitate depression and inflammations to many organs especially lung which is a serious condition and a main cause of mortality in COVID-19. Serotonin (5-HT) is a neurotransmitter and immunomodulator. It improves the mood and it is also responsible for feeling of happiness and calmness. 5-HT was found to regulate innate and adaptive immune responses. In addition, it has shown to play important roles in brain function, hemostasis, sleeping, mood regulation, behaviors and phycological state. It also has important roles in many different peripheral tissues, central nervous system (CNS) and immune cells [25, 26] . The decrease in 5-HT levels is a major cause of depression like symptoms [27] Pathological and physiological conditions may affect the role of serotonin in properly regulating the immune response [28] . Many researches had concluded that elevated serotonin levels plays a vital role in immunity against viral infections [29, 30] . On the other hand, lowered levels of 5-HT had shown a correlation with susceptibility to bacterial infections [27] . COVID-19 had shown to increase the levels of pro-inflammatory cytokines [31] . These elevated levels had shown to increase the rate of metabolism of serotonin due to activation of indoleamine-2,3-dioxygenase (IDO) enzyme that metabolizes tryptophan which is the precursor of serotonin [32] . Moreover, studies had reported that the elevated levels of C-reactive protein (CRP) had shown to be linked to depression like symptoms [33] [34] [35] . Generally, antidepressants are found to augment the immune system response through inhibiting pro-inflammatory factors, in particular CRP, TNF-α, IL-1β and IL-6 [36] . Selective serotonin reuptake inhibitors (SSRIs) are used as antidepressants and anxiolytics by manipulating serotonin within the brain. SSRIs increase serotonin via proscribing its reuptake into the presynaptic cell then increasing the level of serotonin inside the synaptic cleft to bind the postsynaptic receptor [37] . SSRIs have shown an effective role in relieving symptoms of stress and anxiety, which enhances the role of immunity in confronting infection. This class had proved to prevent the elevation in cytokine levels which causes depression [38] [39] [40] [41] . Moreover, SSRIs use had resulted in lowering endotoxin-induced fatigue [39] . In vitro antibacterial effect and modulation of antibiotic activity were also associated with using SSRIs [42] [43] [44] . In COVID-19 patients, SSRIs may help in hindering cytokine release syndrome that is responsible for aggravating sickness progression and the subsequent increase in TNFα [45] . A study had reported the effective role of SSRIs in severe chronic obstructive pulmonary disease where a significant increase of patients' oxygen saturation was observed [46] . Therefore, SSRIs family may help in controlling symptoms of COVID-19 patients due to its reported potent anti-inflammatory activity in different inflammatory disorders [39, 47] Many researches had reported the high therapeutic efficacy of SSRIs via reversal of the oxidative damage by the protective enhancement of antioxidant status following a stress-induced decline [48] . It has shown a significant inhibitory effect on nitric oxide (NO) production in a dose-dependent manner [49] . As a consequence, SSRIs had shown anti-inflammatory and analgesic properties [50] . SSRIs have shown anticoagulant properties [51] making it a promising option for COVID-19 patients who mostly experience venous and arterial thrombosis that is the major cause of mortality. Given the high replicative potential of COVID-19, it is possible that the very high viral burden in the lung leads to a large inflammatory response which is fatal. Fortunately, SSRI was found to have antiviral effects beside being a mood stabilizer. A patent study had reported the efficiency of SSRIs treatment in reducing chemokine and cytokine expression in the infected cells and hence, it has a role in combating infections [52] . SSRIs had shown to potentiate the antiviral potency of certain antivirals [53] . SSRIs had reported HIV receptor and coreceptor downregulation [54] , Ebola virus lowered activity [55] and reduced viral replication of Coxsackievirus B4 [56] by their use beside the antiviral. Sertraline is a member of SSRIs that is deeply suggested as a favorable therapeutic choice for COVID-19 patients because it has a wide therapeutic index and minimal anticholinergic activity which make it a safe option for elderly patients or those with underlying cardiovascular disorders [57] . Sertraline had strong anti-inflammatory effects via decreasing and regulating of pro-inflammatory cytokines [58, 59] . It had significantly increased the activity of antibiotics with some resistant strains of S. aureus, E. Coli and P. aeruginosa. Thus, sertraline is a resistance modifying agent when used in combination with the antibiotics [44] . Also sertraline had reported antiviral efficacy [60] when used effectively in reducing influenza-induced lung inflammation and lowering mortality rate when combined with oseltamivir in a mouse model [53] . Regarding the ideal timing of starting sertraline, it would be advisable to start once respiratory symptom began to be worse or ,in other words, before the onset of acute lung injury which precedes the occurrence of the fatal pneumonia. In this hypothesis, we needed to raise the effective role of serotonin in the activation of T-cells and enhancement of the immune system in COVID-19 patients. This may show a high usefulness for the vulnerable subjects and medical staff who are constantly exposed to fatigue, stress, anxiety and depression caused by COVID-19 pandemic and had shown to destroy the immunity against any viral attack. SSRI would play important roles in COVID-19 infection via treating anxiety and stress, and increasing the number and function of immune cells. Cytokine release syndrome in COVID-19 is expected to be ameliorated by the use of sertraline that lower IL-6 and IL-10 levels. Moreover, we suggest that sertraline may exhibit antiviral effect against COVID-19 but with unknown mechanism of action. We think that understanding the mechanism of halting the viral replication would be an important research area that might benefit the scientific field. We advise giving sertraline to moderate cases of COVID-19 patients as a prophylaxis against lethal pulmonary symptoms and it should be used as an adjuvant therapy to drugs used in the protocol of COVID-19 treatment. This research hypothesis would provide a great benefit in fastening the recovery and reducing mortality rates in COVID-19 patients. Moreover, if using sertraline is found to be effective in preventing the associated ARDS, its global use would be highly beneficial to the humanity. Besides, it is safe, tolerable and highly affordable. The authors declare any conflict of interests or personal relationships that could influence the reported hypothesis and no financial support was received for this manuscript. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle The reproductive Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China Clinical Characteristics of Coronavirus Disease 2019 in China Acute pulmonary embolism and COVID-19 pneumonia: a random association? COVID-19 Complicated by Acute Pulmonary Embolism Interleukin-6 use in COVID-19 pneumonia related macrophage activation syndrome COVID-19) advice for the public Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China Life event, stress and illness The role of the innate immune system in psychiatric disorders Psychological influences on immune function and health Depression and cancer: mechanisms and disease progression Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure Neurobiological mechanisms in major depressive disorder Stress-induced immune dysregulation: implications for wound healing, infectious disease and cancer Stress, depression, the immune system, and cancer The relationship of depression and stressors to immunological assays: a meta-analytic review Dysregulation of immune response in patients with COVID-19 in Wuhan, China The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak -an update on the status Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor alpha and interleukin-6 Serotonin: A Potent Immune Cell Modulator in Autoimmune Diseases Antioxidative properties of serotonin and the bactericidal function of polymorphonuclear phagocytes Role of serotonin in the immune system and in neuroimmune interactions Serotonin hypothesis of psychiatric disorders during HIV infection Serotonin and its precursors as modulators of the immunological responsiveness in mice Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission Constant darkness induces IL-6-dependent depression-like behavior through the NF-κB signaling pathway Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis Modulatory Effects of Antidepressant Classes on the Innate and Adaptive Immune System in Depression SSRI differentiation: pharmacology and pharmacokinetics Cytokines and their role in depression behavior, and immunity. Citalopram reduces endotoxin-induced fatigue Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: A systematic review and meta-analysis New roles of fluoxetine in pharmacology: Antibacterial effect and modulation of antibiotic activity Antimicrobial activity of psychotropic drugs: selective serotonin reuptake inhibitors Sertraline enhances the activity of antimicrobial agents against pathogens of clinical relevance Anti-inflammatory properties of desipramine and fluoxetine Selective serotonin re-uptake inhibitors beyond psychiatry: Are they useful in the treatment of severe, chronic, obstructive pulmonary disease? Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors Antioxidant potential of fluoxetine in comparison to Curcuma longa in restraint-stressed rats Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide Evaluation of the anti-inflammatory and anti-nociceptive effects of different antidepressants in the rat Influence of antidepressants on hemostasis Compositions and methods for treating viral infections Reduction of influenza virus-induced lung inflammation and mortality in animals treated with a phosophodisestrase-4 inhibitor and a selective serotonin reuptake inhibitor The Selective Serotonin Reuptake Inhibitor Citalopram Decreases HIV Receptor and Coreceptor Expression in Immune Cells A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity Persistent infection of human pancreatic cells with Coxsackievirus B4 is cured by fluoxetine A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia Sertraline ameliorates inflammation in CUMS mice and inhibits TNF-alpha-induced inflammation in microglia cells Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs The authors declare any conflict of interests or personal relationships that could influence the reported hypothesis and no financial support was received for this manuscript.